Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LISSETTE SELEM

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1093910499
CMS profile
849816
Location
MIAMI LAKES, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$1,706.25

82 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,596.76 81
Education $109.49 1

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 2; records 51–82 of 82 matching records. This page contains 32 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LISSETTE SELEM

NPI 1093910499 · CMS profile ID 849816

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

MIAMI LAKES, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–82 of 82 matching records. This page contains 32 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1093910499?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LISSETTE SELEM, NPI 1093910499, CMS profile ID 849816. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–82 of 82 matching records. This page contains 32 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1093910499?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). LISSETTE SELEM, NPI 1093910499, CMS profile ID 849816. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–82 of 82 matching records. This page contains 32 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1093910499?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
LISSETTE SELEM, NPI 1093910499, CMS profile ID 849816, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–82 of 82 matching records. This page contains 32 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1093910499?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

82 matching records · $1,706.25 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 82 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–82 of 82.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Otsuka America Pharmaceutical, Inc. $13.8605/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227486975 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.9405/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223840095 CMS
Teva Pharmaceuticals USA, Inc. $10.8805/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247272811 CMS
Teva Pharmaceuticals USA, Inc. $19.7105/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247272809 CMS
Teva Pharmaceuticals USA, Inc. $109.4905/15/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1247272821 CMS
E.R. Squibb & Sons, L.L.C. $25.0005/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184882445 CMS
Otsuka America Pharmaceutical, Inc. $11.6505/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227486972 CMS
Otsuka America Pharmaceutical, Inc. $13.0604/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227486969 CMS
Teva Pharmaceuticals USA, Inc. $2.8104/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247272797 CMS
E.R. Squibb & Sons, L.L.C. $38.9304/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184882431 CMS
ABBVIE INC. $15.8104/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204160260 CMS
Otsuka America Pharmaceutical, Inc. $27.6904/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227486966 CMS
Lundbeck LLC $24.7004/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251845819 CMS
Vanda Pharmaceuticals Inc. $34.2804/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233002151 CMS
Teva Pharmaceuticals USA, Inc. $19.7104/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247272795 CMS
Lundbeck LLC $24.8904/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251845815 CMS
Lundbeck LLC $26.5404/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251845817 CMS
ABBVIE INC. $9.0603/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204160254 CMS
Neurocrine BioSciences, Inc. $39.8003/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1242972550 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.0003/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241397555 CMS
Lundbeck LLC $19.8803/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251845813 CMS
E.R. Squibb & Sons, L.L.C. $24.8803/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184882419 CMS
ABBVIE INC. $25.2002/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204160248 CMS
Otsuka America Pharmaceutical, Inc. $12.4702/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227486962 CMS
Axsome Therapeutics, Inc. $29.2702/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235723976 CMS
ABBVIE INC. $8.8402/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204160238 CMS
Lundbeck LLC $26.7902/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251845811 CMS
Otsuka America Pharmaceutical, Inc. $11.8702/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227486958 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.4402/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241397553 CMS
Alkermes, Inc. $25.0001/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222635792 CMS
Lundbeck LLC $32.7201/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251845809 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.7501/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241397551 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,661.47 99
PY2020 $1,282.97 76
PY2021 $2,787.59 138
PY2022 $2,053.06 106
PY2023 $2,027.20 85
PY2024 $1,183.02 58
PY2025 $1,706.25 82

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $1,017,509.99 227
PY2024 Principal investigator $222,694.28 24
PY2023 Principal investigator $158,931.82 23
PY2022 Recipient $57,167.00 1
PY2022 Principal investigator $132,882.01 9
PY2021 Principal investigator $14,050.00 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

227 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/05/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242368611
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $140.00 12/05/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242368613
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/05/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242368615
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 12/05/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242368617
Principal investigator 1 ACADIA Pharmaceuticals Inc $2,500.00 12/03/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245938250
Principal investigator 1 ACADIA Pharmaceuticals Inc $5,743.00 12/03/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245938252
Principal investigator 1 ACADIA Pharmaceuticals Inc $2,500.00 12/03/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245938254
Principal investigator 1 ACADIA Pharmaceuticals Inc $5,743.00 12/03/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245938256
Principal investigator 1 ACADIA Pharmaceuticals Inc $6,537.00 12/03/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245938258
Principal investigator 1 ACADIA Pharmaceuticals Inc $2,500.00 11/05/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245937605
Principal investigator 1 ACADIA Pharmaceuticals Inc $5,743.00 11/05/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245937607
Principal investigator 1 ACADIA Pharmaceuticals Inc $5,139.00 11/05/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245937609
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 10/10/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242363635
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 10/10/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242363637
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 10/10/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242363639
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 10/10/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242363641
Principal investigator 1 Janssen Research & Development, LLC $5,000.00 10/06/2025 Non-covered Recipient Entity
Interspond Llc
A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) (VENTURA-LT) No dispute reported 06/30/2026 1175302036
Principal investigator 1 Janssen Research & Development, LLC $15,247.00 10/03/2025 Non-covered Recipient Entity
Interspond Llc
A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Aticaprant 10 mg and 5 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate to Severe Anhedonia and Inadequate Response to Current Antidepressant Therapy. No dispute reported 06/30/2026 1175302323
Principal investigator 1 ACADIA Pharmaceuticals Inc $2,500.00 10/02/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245937236
Principal investigator 1 ACADIA Pharmaceuticals Inc $5,743.00 10/02/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245937238
Principal investigator 1 ACADIA Pharmaceuticals Inc $2,500.00 10/02/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245937240
Principal investigator 1 ACADIA Pharmaceuticals Inc $5,743.00 10/02/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245937242
Principal investigator 1 ACADIA Pharmaceuticals Inc $6,537.00 10/02/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245937244
Principal investigator 1 ACADIA Pharmaceuticals Inc $4,126.00 10/02/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245937246
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,000.00 09/25/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-008 No dispute reported 06/30/2026 1245936213
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,500.00 09/25/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-008 No dispute reported 06/30/2026 1245936215
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,000.00 09/25/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-008 No dispute reported 06/30/2026 1245936217
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 09/22/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242359036
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 09/22/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242359038
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 09/22/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242359040
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $102.00 09/22/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242359042
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 09/22/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242359044
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 09/22/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242359046
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,500.00 09/17/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-008 No dispute reported 06/30/2026 1245936155
Principal investigator 1 ACADIA Pharmaceuticals Inc $2,500.00 09/17/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-008 No dispute reported 06/30/2026 1245936157
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,500.00 09/17/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-008 No dispute reported 06/30/2026 1245936159
Principal investigator 1 ACADIA Pharmaceuticals Inc $12,500.00 09/17/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-008 No dispute reported 06/30/2026 1245936161
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,000.00 09/03/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245935853
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,500.00 09/03/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245935855
Principal investigator 1 ACADIA Pharmaceuticals Inc $12,500.00 09/03/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245935857
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,000.00 09/03/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245935859
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 08/08/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242356848
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 08/08/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242356850
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 08/08/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242356852
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 08/08/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242356854
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 08/08/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242356856
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 08/08/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242356858
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 08/08/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242356860
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 08/08/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242356862
Principal investigator 1 ACADIA Pharmaceuticals Inc $1,500.00 08/06/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245935471
Principal investigator 1 ACADIA Pharmaceuticals Inc $2,500.00 08/06/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ACP-204-006 No dispute reported 06/30/2026 1245935473
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,044.85 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352630
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352632
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $137.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352634
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $48.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352638
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $98.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352640
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352965
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352967
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352969
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352971
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352973
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352975
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352977
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $137.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352979
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $98.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352981
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $102.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352983
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $137.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352985
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $137.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352987
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $98.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352989
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $98.00 07/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242352991
Principal investigator 1 Janssen Research & Development, LLC $500.00 05/16/2025 Non-covered Recipient Entity
Interspond Llc
A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Aticaprant 10 mg and 5 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate to Severe Anhedonia and Inadequate Response to Current Antidepressant Therapy. No dispute reported 06/30/2026 1175302213
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,812.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345859
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345861
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2,478.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345869
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345871
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345873
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345875
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,137.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345881
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345883
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345885
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345887
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345889
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345891
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345895
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345897
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345899
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,812.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345901
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2,478.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345903
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345905
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345907
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345909
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345911
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345913
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345915
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,812.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345917
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345919
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2,478.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345921
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345923
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345925
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345927
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345929
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345931
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345933
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $8,173.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345935
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345937
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345939
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,812.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345941
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345943
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2,478.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345945
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345947
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345949
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345951
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345953
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345955
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345957
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345959
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345961
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345963
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345965
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345967
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345969
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,137.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345971
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345973
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345975
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345977
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345979
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345981
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345983
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 05/07/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242345985
Principal investigator 1 Janssen Research & Development, LLC $12,896.00 04/23/2025 Non-covered Recipient Entity
Interspond Llc
A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) (VENTURA-LT) No dispute reported 06/30/2026 1175302064
Principal investigator 1 Janssen Research & Development, LLC $728.00 04/18/2025 Non-covered Recipient Entity
Interspond Llc
A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Aticaprant 10 mg and 5 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate to Severe Anhedonia and Inadequate Response to Current Antidepressant Therapy. No dispute reported 06/30/2026 1175302135
Principal investigator 1 Janssen Research & Development, LLC $21,378.00 04/16/2025 Non-covered Recipient Entity
Interspond Llc
A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Aticaprant 10 mg and 5 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate to Severe Anhedonia and Inadequate Response to Current Antidepressant Therapy. No dispute reported 06/30/2026 1175302175
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9,650.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341426
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341428
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341430
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341432
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341434
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341436
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341438
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9,650.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341472
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341474
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341476
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341478
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341480
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341482
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341484
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9,650.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341516
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9,650.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341518
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341520
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341522
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341524
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341526
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341528
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341562
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9,650.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341566
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341568
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341570
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341572
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341574
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341602
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341604
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $137.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341606
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $98.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341608
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341610
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341614
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341636
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341638
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $8,687.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341640
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341668
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $7,281.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341670
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341672
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341674
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341676
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341678
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $8,173.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341680
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341708
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341710
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341712
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341714
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341716
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341718
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,137.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341720
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341740
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341742
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341744
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341746
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $102.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341748
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $137.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341750
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $137.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341752
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $48.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341782
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $98.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341784
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $98.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341786
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $8,687.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341788
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341790
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $7,281.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341792
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $8,687.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341794
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341826
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $7,281.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341828
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341830
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341832
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341834
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341836
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $8,173.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341838
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $8,687.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341862
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $7,281.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341864
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341866
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341868
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341870
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $8,173.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341872
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341874
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341904
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341906
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341908
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341910
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,137.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341912
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341914
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341916
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341940
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341942
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,236.00 04/11/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
ITI-007-451 No dispute reported 06/30/2026 1242341968
Principal investigator 1 Janssen Research & Development, LLC $8,730.00 04/02/2025 Non-covered Recipient Entity
Interspond Llc
A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) (VENTURA-LT) No dispute reported 06/30/2026 1175301994
Principal investigator 1 Janssen Research & Development, LLC $4,529.00 02/24/2025 Non-covered Recipient Entity
Interspond Llc
A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Aticaprant 10 mg and 5 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate to Severe Anhedonia and Inadequate Response to Current Antidepressant Therapy. No dispute reported 06/30/2026 1175302166
Principal investigator 1 Janssen Research & Development, LLC $12,076.00 02/24/2025 Non-covered Recipient Entity
Interspond Llc
A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) (VENTURA-LT) No dispute reported 06/30/2026 1175302183
Principal investigator 1 Eli Lilly and Company $29,035.14 02/18/2025 Non-covered Recipient Entity
EZY MEDICAL RESEARCH CO
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE No dispute reported 06/30/2026 1187881512
Principal investigator 1 Janssen Research & Development, LLC $22,983.00 01/24/2025 Non-covered Recipient Entity
Interspond Llc
A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) (VENTURA-LT) No dispute reported 06/30/2026 1175302152
Principal investigator 1 Janssen Research & Development, LLC $500.00 01/17/2025 Non-covered Recipient Entity
Interspond Llc
A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Aticaprant 10 mg and 5 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate to Severe Anhedonia and Inadequate Response to Current Antidepressant Therapy. No dispute reported 06/30/2026 1175302332
Principal investigator 1 Janssen Research & Development, LLC $8,768.00 01/03/2025 Non-covered Recipient Entity
Interspond Llc
A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) (VENTURA-LT) No dispute reported 06/30/2026 1175301928